Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia · Delayed Price · Currency is AUD 0.2600
-0.0080 (-3.08%)
Mar 11, 2026, 4:10 PM AEST
ASX:PAR Revenue
Paradigm Biopharmaceuticals had revenue of 25.15K AUD in the half year ending December 31, 2025. This brings the company's revenue in the last twelve months to 8.45K, down -49.40% year-over-year.
Revenue (ttm)
8.45K
Revenue Growth
-49.40%
P/S Ratio
13,515.52
Revenue / Employee
n/a
Employees
n/a
Market Cap
114.21M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | - | - | - |
| Jun 30, 2024 | - | - | - |
| Jun 30, 2023 | - | - | - |
| Jun 30, 2022 | 79.22K | 58.67K | 285.52% |
| Jun 30, 2021 | 20.55K | - | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Botanix Pharmaceuticals | 21.92M |
| Radiopharm Theranostics | 16.28M |
| Starpharma Holdings | 14.58M |
| Actinogen Medical | 7.36M |
| Alterity Therapeutics | 6.64M |
| Imugene | 3.94M |
| Arovella Therapeutics | 3.21M |
| Cynata Therapeutics | 1.69M |